The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
August 27th 2025
The FDA's approvals follows new COVID-19 guidance announced by the commissioner of the agency in May 2025, focusing future approvals on older adults.
Adults With High Ratio of Non-HDL Cholesterol to HDL Cholesterol Have Higher Sarcopenia Risk
March 7th 2025Sarcopenia, a progressive skeletal order that involves the accelerated loss of muscle mass and function, is associated with adverse outcomes such as functional decline, frailty, and mortality.
Read More
FDA Issues New Labeling Changes Clarifying Safety of Testosterone Products Following Clinical Trials
March 4th 2025The FDA is issuing new changes to labels on testosterone products, clarifying that there are no increases in major cardiac events among men with hypogonadism but noting an increase in blood pressure with the use of such products.
Read More